What Happened?
Lexington, MA-based Agenus Resigned Alex Duncan as Chief Technology Officer
About the Company
Agenus is an immuno-oncology company driven by innovation and speed. Our goal is to treat cancers with novel combinations utilizing our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines and adjuvants. In addition to a broad portfolio, we have an accomplished team of scientists, novel technology platforms and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. With our remarkable combination of science and people, we believe that we are uniquely positioned to bring curative treatments to cancer patients.
About the Person
Alex Duncan is Chief Technology Officer at Agenus. Previously, Alex held various senior IT leadership roles in the industry.
Info Source
News
Short Profile